Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 for Skin Function in Type 2 Diabetes
NCT03313297Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD4017 in type 2 diabetes mellitus (T2DM), sponsored by University of Leeds. Started Apr 2018; status: completed.
02
Drugs
AZD4017
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03313297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03313297.